Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1987 2
1988 3
1989 2
1990 1
1991 2
1993 3
1994 3
1995 3
1996 4
1997 2
1998 2
1999 7
2000 4
2001 2
2003 4
2004 2
2005 7
2006 4
2008 2
2009 9
2010 9
2011 8
2012 13
2013 13
2014 9
2015 13
2016 6
2017 4
2018 5
2019 8
2020 9
2021 13
2022 8
Text availability
Article attribute
Article type
Publication date

Search Results

169 results
Results by year
Filters applied: . Clear all
Page 1
WHO-EORTC classification for cutaneous lymphomas.
Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, Grange F, Harris NL, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ. Willemze R, et al. Among authors: duncan lm. Blood. 2005 May 15;105(10):3768-85. doi: 10.1182/blood-2004-09-3502. Epub 2005 Feb 3. Blood. 2005. PMID: 15692063 Free article. Review.
Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway.
Lee K, Evans MG, Yang L, Ng S, Snowden C, Khodadoust M, Brown RA, Trum NA, Querfeld C, Doan LT, Song J, Zhang H, Gru AA, Wood GS, Wada DA, Shanmugam V, Haun PL, Aster JC, Duncan LM, Guitart J, Weinstock DM, Nardi V, Choi J. Lee K, et al. Among authors: duncan lm. Blood. 2021 Dec 9;138(23):2435-2440. doi: 10.1182/blood.2021012536. Blood. 2021. PMID: 34432866
Resistance to checkpoint blockade therapy through inactivation of antigen presentation.
Sade-Feldman M, Jiao YJ, Chen JH, Rooney MS, Barzily-Rokni M, Eliane JP, Bjorgaard SL, Hammond MR, Vitzthum H, Blackmon SM, Frederick DT, Hazar-Rethinam M, Nadres BA, Van Seventer EE, Shukla SA, Yizhak K, Ray JP, Rosebrock D, Livitz D, Adalsteinsson V, Getz G, Duncan LM, Li B, Corcoran RB, Lawrence DP, Stemmer-Rachamimov A, Boland GM, Landau DA, Flaherty KT, Sullivan RJ, Hacohen N. Sade-Feldman M, et al. Among authors: duncan lm. Nat Commun. 2017 Oct 26;8(1):1136. doi: 10.1038/s41467-017-01062-w. Nat Commun. 2017. PMID: 29070816 Free PMC article.
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.
Meng B, Kemp SA, Papa G, Datir R, Ferreira IATM, Marelli S, Harvey WT, Lytras S, Mohamed A, Gallo G, Thakur N, Collier DA, Mlcochova P; COVID-19 Genomics UK (COG-UK) Consortium, Duncan LM, Carabelli AM, Kenyon JC, Lever AM, De Marco A, Saliba C, Culap K, Cameroni E, Matheson NJ, Piccoli L, Corti D, James LC, Robertson DL, Bailey D, Gupta RK. Meng B, et al. Among authors: duncan lm. Cell Rep. 2021 Jun 29;35(13):109292. doi: 10.1016/j.celrep.2021.109292. Epub 2021 Jun 8. Cell Rep. 2021. PMID: 34166617 Free PMC article.
Melanoma staging: where are we now?
Piris A, Lobo AC, Duncan LM. Piris A, et al. Among authors: duncan lm. Dermatol Clin. 2012 Oct;30(4):581-92, v. doi: 10.1016/j.det.2012.06.001. Epub 2012 Jul 31. Dermatol Clin. 2012. PMID: 23021047 Review.
Warfarin-induced skin necrosis.
Nazarian RM, Van Cott EM, Zembowicz A, Duncan LM. Nazarian RM, et al. Among authors: duncan lm. J Am Acad Dermatol. 2009 Aug;61(2):325-32. doi: 10.1016/j.jaad.2008.12.039. J Am Acad Dermatol. 2009. PMID: 19615543 Review.
The classification of cutaneous melanoma.
Duncan LM. Duncan LM. Hematol Oncol Clin North Am. 2009 Jun;23(3):501-13, ix. doi: 10.1016/j.hoc.2009.03.013. Hematol Oncol Clin North Am. 2009. PMID: 19464599 Review.
169 results